Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 324, Issue 5, Pages 437-438Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/jama.2020.12190
Keywords
-
Categories
Ask authors/readers for more resources
This Viewpoint discusses the mechanisms of the 5 leading COVID-19 vaccine candidates-2 messenger RNA vaccines, 1 recombinant VSV vector product, and 2 replication-defective adenovirus vector approaches-and emphasizes the need to demonstrate safety as well as efficacy to facilitate broad uptake by the public.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
